{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:38:28Z","timestamp":1792460308837,"version":"4.5.0"},"reference-count":28,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"unspecified","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2021,12,19]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autism spectrum disorders (ASDs) are a wide range of behavioural disabilities for which there are no definite interventional modalities available. Remedial therapies remain the only option but with varying outcomes. We have evaluated the Childhood Autism Rating Scale (CARS) and alpha-synuclein levels in this parallel-group, multiple-arm pilot clinical study after supplementation with a biological response modifier beta-glucan food supplement (Nichi Glucan).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Six subjects with ASD (n=6) Gr. 1 underwent conventional treatment comprising remedial behavioural therapies and L-carnosine 500\u2009mg per day, and 12 subjects (n=12) Gr. 2 underwent supplementation with the Nichi Glucan 0.5\u2009g two times per day along with the conventional treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There was a significant decrease in the CARS score in all of the children of the Nichi Glucan Gr.2 compared with the control (p=0.034517). Plasma levels of alpha-synuclein were significantly higher in Gr. 2 (Nichi Glucan) than in the control group Gr. 1 (p=0.091701).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Improvement of the behavioural pattern CARS score and a correlating alpha-synuclein level, followed by a safe beta-glucan food supplement, warrants further research on other parameters, such as gut-microbiota evaluation, and relevant neuronal biomarkers which is likely to cast light on novel solutions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjno-2021-000203","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T11:41:27Z","timestamp":1642506087000},"page":"e000203","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":28,"title":["Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study"],"prefix":"10.1136","volume":"4","author":[{"given":"Kadalraja","family":"Raghavan","sequence":"first","affiliation":[{"name":"Department of Paediatric Neurology, Kenmax Medical Services Pvt. Ltd, Madurai, India"},{"name":"Department of Paediatric Neurology, Jesuit Antonyraj memorial Inter-disciplinary Centre for Advanced Rehabilitation and Education (JAICARE), Madurai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidyasagar Devaprasad","family":"Dedeepiya","sequence":"additional","affiliation":[{"name":"Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobunao","family":"Ikewaki","sequence":"additional","affiliation":[{"name":"Department of Medical Life Science, Kyushu University of Health and Welfare, Nobeoka, Miyazaki, Japan"},{"name":"Institute of Immunology, Junsei Educational Institute, Nobeoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Sonoda","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Junsei Educational Institute, Nobeoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Centre for Advancing Clinical Research (CACR), University of Yamanashi Faculty of Medicine Graduate School of Medicine, Chuo, Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthilkumar","family":"Preethy","sequence":"additional","affiliation":[{"name":"Fujio-Eiji Academic Terrain (FEAT), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2646-2687","authenticated-orcid":false,"given":"Samuel JK","family":"Abraham","sequence":"additional","affiliation":[{"name":"Centre for Advancing Clinical Research (CACR), University of Yamanashi Faculty of Medicine Graduate School of Medicine, Chuo, Yamanashi, Japan"},{"name":"Antony- Xavier Interdisciplinary Scholastics (AXIS), GN Corporation Co Ltd, Kofu, Yamanashi Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"key":"2025072811191077000_4.1.e000203.1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000513935","article-title":"Plasma levels of alpha and gamma synucleins in autism spectrum disorder: an indicator of severity","volume":"30","author":"Al-Mazidi","year":"2021","journal-title":"Med Princ Pract"},{"key":"2025072811191077000_4.1.e000203.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.12.023"},{"key":"2025072811191077000_4.1.e000203.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.06.134"},{"key":"2025072811191077000_4.1.e000203.4","article-title":"Estimation of alpha-synuclein monomer and oligomer levels in the saliva of the children with autism spectrum disorder: a possibility for an early diagnosis","volume":"12","author":"Siddique","year":"2020","journal-title":"Cureus"},{"key":"2025072811191077000_4.1.e000203.5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/4503871","article-title":"Significant changes in plasma alpha-synuclein and beta-synuclein levels in male children with autism spectrum disorder","volume":"2018","author":"Sriwimol","year":"2018","journal-title":"Biomed Res Int"},{"key":"2025072811191077000_4.1.e000203.6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1055\/s-0035-1565273","article-title":"Low serum level \u03b1-synuclein and tau protein in autism spectrum disorder compared to controls","volume":"46","author":"Kadak","year":"2015","journal-title":"Neuropediatrics"},{"key":"2025072811191077000_4.1.e000203.7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092115","article-title":"The possible role of the Microbiota-Gut-Brain-Axis in autism spectrum disorder","volume":"20","author":"Srikantha","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025072811191077000_4.1.e000203.8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/nutrit\/nuz092","article-title":"Nutritional interventions for autism spectrum disorder","volume":"78","author":"Karhu","year":"2020","journal-title":"Nutr Rev"},{"key":"2025072811191077000_4.1.e000203.9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijbiomac.2020.05.180","article-title":"Yeast \u03b2-glucan alleviates cognitive deficit by regulating gut microbiota and metabolites in A\u03b2\n                  1-42-induced AD-like mice","volume":"161","author":"Xu","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"2025072811191077000_4.1.e000203.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2007.tb03982.x"},{"key":"2025072811191077000_4.1.e000203.11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/895370","article-title":"Potential effects of nichi glucan as a food supplement for diabetes mellitus and hyperlipidemia: preliminary findings from the study on three patients from India","volume":"2012","author":"Dedeepiya","year":"2012","journal-title":"Case Rep Med"},{"key":"2025072811191077000_4.1.e000203.12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/19390211.2013.859211","article-title":"Beneficial effects of black yeast derived 1-3, 1-6 Beta Glucan-Nichi Glucan in a dyslipidemic individual of Indian origin--a case report","volume":"11","author":"Ganesh","year":"2014","journal-title":"J Diet Suppl"},{"key":"2025072811191077000_4.1.e000203.13","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1080\/21645515.2021.1880210","article-title":"\u03b2-glucans: wide-spectrum immune-balancing food-supplement-based enteric (\u03b2-WIFE) vaccine adjuvant approach to COVID-19","volume":"17","author":"Ikewaki","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"2025072811191077000_4.1.e000203.14","doi-asserted-by":"publisher","DOI":"10.1017\/S1740925X12000142"},{"key":"2025072811191077000_4.1.e000203.15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3389\/fped.2018.00264","article-title":"Children with autism spectrum disorder with regression exhibit a different profile in plasma cytokines and adhesion molecules compared to children without such regression","volume":"6","author":"Gomez-Fernandez","year":"2018","journal-title":"Front Pediatr"},{"key":"2025072811191077000_4.1.e000203.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2009.04.039"},{"key":"2025072811191077000_4.1.e000203.17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117554","article-title":"Potentials to alleviate coagulopathy and enhance microglial function of beta (\u03b2)- glucans, making them worth a clinical study for COVID-19\u2019s neurological sequalae","volume":"427","author":"Raghavan","year":"2021","journal-title":"J Neurol Sci"},{"key":"2025072811191077000_4.1.e000203.18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s40168-020-00920-y","article-title":"\u03b2-glucan attenuates cognitive impairment via the gut-brain axis in diet-induced obese mice","volume":"8","author":"Shi","year":"2020","journal-title":"Microbiome"},{"key":"2025072811191077000_4.1.e000203.19","first-page":"1","article-title":"Response (minimum clinically relevant change) in ASD symptoms after an intervention according to CARS-2: consensus from an expert elicitation procedure","volume":"55","author":"Jurek","year":"2021","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2025072811191077000_4.1.e000203.20","doi-asserted-by":"publisher","DOI":"10.1186\/1866-1955-6-44"},{"key":"2025072811191077000_4.1.e000203.21","doi-asserted-by":"crossref","unstructured":"Raghavan K , Dedeepiya VD , Kandaswamy R . Improvement of sleep patterns and serum melatonin levels in children with autism spectrum disorders after consumption of beta-1,3\/1,6-glucan in a pilot clinical study. Research Square 2021.doi:10.21203\/rs.3.rs-701988\/v1","DOI":"10.21203\/rs.3.rs-701988\/v1"},{"key":"2025072811191077000_4.1.e000203.22","doi-asserted-by":"crossref","first-page":"01","DOI":"10.21776\/ub.mnj.2016.002.01.2","article-title":"The effect of beta glucan of saccharomyces cerevisae on the decrease of alpha synuclein expression in the brain substantia nigra of parkinson\u2019s wistar strain rats (rattus novergicus) model induced with rotenone","volume":"2","author":"Rahayu","year":"2016","journal-title":"MNJ"},{"key":"2025072811191077000_4.1.e000203.23","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/1541-4337.12565","article-title":"Effectiveness of probiotics, prebiotics, and prebiotic-like components in common functional foods","volume":"19","author":"Peng","year":"2020","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"2025072811191077000_4.1.e000203.24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.638867","article-title":"Microbiome or infections: Amyloid-Containing biofilms as a trigger for complex human diseases","volume":"12","author":"Miller","year":"2021","journal-title":"Front Immunol"},{"key":"2025072811191077000_4.1.e000203.25","doi-asserted-by":"crossref","unstructured":"Raghavan K , Dedeepiya VD , Yamamoto N . Beneficial reconstitution of gut microbiota and control of alpha-synuclein and curli-amyloids-producing enterobacteria, by beta 1,3-1,6 glucans in a clinical pilot study of autism and potentials in neurodegenerative diseases. medRxiv 2021.doi:10.1101\/2021.10.26.21265505","DOI":"10.1101\/2021.10.26.21265505"},{"key":"2025072811191077000_4.1.e000203.26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1909110117"},{"key":"2025072811191077000_4.1.e000203.27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117554","article-title":"Potentials to alleviate coagulopathy and enhance microglial function of beta (\u03b2)- glucans, making them worth a clinical study for COVID-19's neurological sequalae","volume":"427","author":"Raghavan","year":"2021","journal-title":"J Neurol Sci"},{"key":"2025072811191077000_4.1.e000203.28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/7486431","article-title":"Improving outcome in infantile autism with folate receptor autoimmunity and nutritional derangements: a self-controlled trial","volume":"2019","author":"Ramaekers","year":"2019","journal-title":"Autism Res Treat"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2021-000203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T18:19:20Z","timestamp":1753726760000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2021-000203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,18]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/bmjno-2021-000203"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2021-000203","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.28.21259619","asserted-by":"object"}]},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}